Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

The broader implications of managing statins at the end of life.

Stevenson JP, Currow DC, Abernethy AP.

J Palliat Care. 2007 Autumn;23(3):188-9; author reply 189. No abstract available.

PMID:
18069441
2.

Evidence-based deprescribing of statins in patients with advanced illness.

Holmes HM, Todd A.

JAMA Intern Med. 2015 May;175(5):701-2. doi: 10.1001/jamainternmed.2015.0328. No abstract available.

3.

Statins: numbers needed to treat and personal decision making.

Bhopal RS.

BMJ. 2014 Aug 5;349:g4980. doi: 10.1136/bmj.g4980. No abstract available.

PMID:
25095785
4.

Statins and renal function. Is the compound and dose making a difference?

Athyros VG, Karagiannis A, Kakafika A, Elisaf M, Mikhailidis DP.

Nephrol Dial Transplant. 2007 Mar;22(3):963-4; author reply 964. Epub 2007 Jan 25. No abstract available.

PMID:
17255130
5.

Palliative care: Discontinuation of statins assessed.

Mearns BM.

Nat Rev Cardiol. 2015 Jun;12(6):319. doi: 10.1038/nrcardio.2015.59. Epub 2015 Apr 14. No abstract available.

PMID:
25869334
6.

ACP Journal Club: in palliative care, discontinuation of statins did not differ from continuation for mortality.

Stockler M.

Ann Intern Med. 2015 Aug 18;163(4):JC7. doi: 10.7326/ACPJC-2015-163-4-007. No abstract available.

PMID:
26280442
7.

Treatment with statins in high-risk patients: relevance of time to titration of dose and adverse outcomes.

Thadani U.

Am J Cardiovasc Drugs. 2009;9(3):211-2; author reply 212. doi: 10.2165/00129784-200909030-00007. No abstract available.

PMID:
19463025
8.

Terminally ill patients could benefit from stopping statins, study says.

Wise J.

BMJ. 2015 Mar 23;350:h1620. doi: 10.1136/bmj.h1620. No abstract available.

PMID:
25801089
9.

[Effect of delay statins withdrawal during admission in medical units].

Ruiz-Bailén M.

Med Intensiva. 2010 May;34(4):268-72. doi: 10.1016/j.medin.2009.11.012. Epub 2010 Jan 22. Spanish.

10.

Stopping statins is bad for your health.

Sherman FT.

Geriatrics. 2004 Nov;59(11):8, 10. No abstract available.

PMID:
15615155
11.

Non-cancer medications for patients with incurable cancer: time to stop and think?

Hall PS, Lord SR, El-Laboudi A, Seymour MT.

Br J Gen Pract. 2010 Apr;60(573):243-4. doi: 10.3399/bjgp10X483887. No abstract available.

12.

Statins: the case for higher, individualized starting doses.

Jones PH.

Cleve Clin J Med. 2005 Sep;72(9):811-6. Review.

PMID:
16193828
13.

Statins and antioxidant vitamins: should co-administration be avoided?

Tousoulis D, Antoniades C, Stefanadis C.

J Am Coll Cardiol. 2006 Mar 21;47(6):1237; author reply 1237-8. Epub 2006 Feb 23. No abstract available.

14.

Pleiotropic effects of statins: acutely good, but chronically bad?

Schulz R.

J Am Coll Cardiol. 2005 Apr 19;45(8):1292-4. No abstract available.

15.

Nonprescription statins: not ready for prime time.

Whayne TF Jr.

Am J Cardiol. 2008 Mar 1;101(5):745-6; author reply 746. doi: 10.1016/j.amjcard.2007.09.112. No abstract available.

PMID:
18308034
16.

Pleiotropic effects of statins in the prevention of coronary heart disease--potential side effects.

Okuyama H, Ichikawa Y, Sun Y, Hamazaki T, Lands WE.

World Rev Nutr Diet. 2007;96:55-66. No abstract available.

PMID:
17167280
17.

Stopping statins.

Stone NJ.

Circulation. 2004 Oct 19;110(16):2280-2. No abstract available.

18.

Statins and heart failure.

Athyros VG, Karagiannis A, Mikhailidis DP.

J Am Coll Cardiol. 2010 Apr 13;55(15):1644-5; author reply 1646. doi: 10.1016/j.jacc.2009.11.071. No abstract available.

19.

Shifting statins from clinic to critical care.

Sullivan RA, McCullough PA.

J Interv Cardiol. 2002 Oct;15(5):431-4. No abstract available.

PMID:
12440192
20.

Intensive statin therapy for treating acute coronary syndromes.

Ray KK, Cannon CP.

Expert Opin Investig Drugs. 2006 Oct;15(10):1151-9. Review.

PMID:
16989592

Supplemental Content

Support Center